Targeted radiopharmaceuticals offer new hope for longer'healthspans '
Mark Crockett, MD, chief medical officer at TeleDaaS.Americans today can expect to live long lives. However, increased longevity has brought on a troubling rise in chronic disease, diminishing the quality of life later in life. A 2018 study from the U.S. Centers for Disease Control and Prevention (CDC) found that more than a quarter of U.S. adults now battle multiple chronic conditions, up from 22% in 2001. We may be living longer, but more Americans struggle through these extra years in poor health — presenting a pressing need to extend not just lifespans but “healthspans.” An emerging field of precision radiopharm...
Source: AuntMinnie.com Headlines - March 15, 2024 Category: Radiology Tags: Molecular Imaging Source Type: news

Does breast radiation therapy raise risk of skin cancer?
Radiation therapy for breast cancer treatment leads to an increased risk of skin cancer, according to research published March 8 in JAMA Network Open. A team led by Shawheen Rezaei from Stanford University found that the risk of non-keratinocyte skin cancer diagnosis such as melanoma and hemangiosarcoma after breast cancer treatment with radiation was more than 50% higher. “Although occurrences of non-keratinocyte skin cancers are rare, physicians should be aware of this elevated risk to help inform follow-up care,” the Rezaei team wrote. While breast cancer treatment strategies have improved over the decades, survi...
Source: AuntMinnie.com Headlines - March 11, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Womens Imaging Breast Breast Imaging Source Type: news

Novel Therapy Promising for Radiation-Induced Oral Mucositis
(MedPage Today) -- The first-in-class uridine phosphorylase inhibitor TK-90 almost completely eliminated severe oral mucositis (SOM) in patients with non-metastatic squamous cell carcinoma of the head and neck who underwent radiation therapy, a... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 5, 2024 Category: Hematology Source Type: news

BAMF Health to partner with Corewell Health
BAMF Health and Corewell Health Haworth Innovative Therapeutics Clinic plan to collaborate on a clinical trial to test targeted radiation therapy for cancer patients. The phase I trial is sponsored by Y-mAbs Therapeutics and will include both adolescent and adult patients with recurrent or resistant small-cell lung cancer, sarcoma, and malignant melanoma. Trial participants will receive tumor-targeting treatment with an antibody that binds to a protein called GD-2 on the surface of the cancer cells, then a radioisotope infusion that binds to the antibody and delivers the radiation to cancer cells, BAMF Health said. (Sourc...
Source: AuntMinnie.com Headlines - March 4, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news

Vismodegib-RT Regimen Achieves High Rate of Disease Control in Head and Neck BCC
(MedPage Today) -- More than 90% of patients with locally advanced basal cell carcinoma (BCC) of the head and neck achieved locoregional control (LRC) with vismodegib (Erivedge) and radiation therapy (RT), a small clinical trial showed. LRC at... (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - March 1, 2024 Category: Radiology Source Type: news

Innovative chemotherapy approach shows promise against lung cancer
Lung cancer is not the most common form of cancer, but it is by far the deadliest. Despite treatments such as surgery, radiation therapy and chemotherapy, only about a quarter of all people with the disease will live more than five years after diagnosis, and lung cancer kills more than 1.8 million people worldwide each year, according to the World Health Organization. (Source: World Pharma News)
Source: World Pharma News - February 26, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

ASRT launches new public awareness campaign
The American Society of Radiologic Technologists (ASRT) has partnered with medical imaging professional and actor, Michael Benzaia, for its new "Be Seen" campaign to raise public awareness about the role of medical imaging and radiation therapy professionals in patient diagnosis, intervention, and treatment. Benzaia, who is known for his on-screen medical professional roles in shows such as "General Hospital," "How to Get Away with Murder," "Law & Order," and "The Blacklist," has also worked as a radiographer and CT technologist. Benzaia entered the medical imaging field after first experiencing the world of radiology whi...
Source: AuntMinnie.com Headlines - February 23, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Radiologic Technologist Source Type: news

Immunotherapy Before Sarcoma Surgery Improves Outcomes
Immunotherapy can improve outcomes in patients undergoing surgery for soft-tissue sarcomaImmunotherapy and radiation therapy prior to surgery led to 90% of patients having nearly all cancer cleared from their bodiesOverall five-year survival rates... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 15, 2024 Category: General Medicine Source Type: news

Radiation oncology leaders talk Medicare payment reform
Radiation oncology organizations have come together in an effort to reform Medicare payments for radiation therapy services. The organizations include the American College of Radiation Oncology (ACRO), the American College of Radiology (ACR), the American Society for Radiation Oncology (ASTRO), and the American Society of Clinical Oncology (ASCO). The alliance comes in the wake of cuts to Medicare payments for radiation therapy services, which the organizations say threatens patient access to cancer care. Join Luh, MD, from the ACR and Sameer Keole, MD, president-elect of ASTRO spoke with AuntMinnie.com on the alliance's...
Source: AuntMinnie.com Headlines - February 14, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Radiation Oncology Source Type: news

DOSIsoft receives FDA clearance for ThinkQA Secondary Dose Check
DOSIsoft has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ThinkQA (Edition 2) Secondary Dose Check. ThinkQA is a tool for patient quality assurance for external beam radiation therapy (EBRT). It offers automated and 3D independent calculation-based dose verification for both offline and online adaptive workflows. DOSIsoft highlighted ThinkQA's web platform and dashboard for qualified professional users to visualize 3D dose distribution comparisons and key dosimetric indicators. These include whole matrix differential and cumulative dose volume histograms and gamma index agreements on...
Source: AuntMinnie.com Headlines - February 13, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news

Quebec cancer center first in Canada to use Accuray's Radixact system
Montérégie Integrated Cancer Center in Quebec, Canada, part of Charles-LeMoyne Hospital, is the first center in the country to treat cancer patients using Accuray's Radixact radiation therapy delivery system. A second Radixact system is scheduled to be installed at the center later in 2024. The system at the Montérégie center also incorporates the Accuray exclusive ClearRT helical fan-beam kVCT imaging solution and Synchrony motion adaptation technology. Combined, this allows for clinicians to acquire diagnostic-like quality CT images along with tracking, detecting, and correcting for tumor movement in real-time, the ...
Source: AuntMinnie.com Headlines - February 13, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news

SBRT Shows Promise in Nonspinal Bone Mets SBRT Shows Promise in Nonspinal Bone Mets
Dose-escalation through stereotactic body radiation therapy (SBRT) provides durable local control and pain responses that exceed historical outcomes with conventional radiotherapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 5, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news

RaySearch highlights installation milepost
RaySearch Laboratories has installed more than 1,000 RayStation cancer treatment planning systems worldwide, with the latest in a radiation therapy center in Karnataka, India. The first version of RayStation was launched in 2009 and the system is now available in cancer centers in 43 countries worldwide, the company said. The U.S. has the largest number of centers using the system, at 285, followed by Japan with around 220 centers, and China with 90, RaySearch said. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 31, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news

ASRT awards $10,000 grant
Jacob Manning, RT, of the University of AlabamaJacob Manning, RT, of the University of Alabama has received a $10,000 research grant from the American Society of Radiologic Technologists (ASRT) to evaluate patient immobilization masks for bacteria that cause infections. Little information exists about infectious pathogens associated with thermoplastic materials used to construct masks, Manning explained, in a news release from the ASRT. The research will explore whether patient masks are contaminated with Clostridioides difficile, for instance, and seek to identify other types of bacteria recovered from patient masks and ...
Source: AuntMinnie.com Headlines - January 31, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Radiologic Technologist Source Type: news

Study Supports High-Dose RT, Long-Term ADT as Standard for High-Risk Prostate Cancer
(MedPage Today) -- SAN FRANCISCO -- Men with high-risk localized prostate cancer lived significantly longer with dose-escalated radiation therapy (RT) plus long-term androgen deprivation therapy (ADT), according to long-term follow-up from a... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 26, 2024 Category: Hematology Source Type: news